Serial Number | 79400932 |
Word Mark | DINGGUI |
Filing Date | Thursday, January 25, 2024 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, April 1, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | Tuesday, April 1, 2025 |
Description of Mark | The mark consists of the stylized wording "DINGGUI" in red and outlined in black, yellow, and orange. |
Goods and Services | Preparations for the treatment of asthma; medical preparations and drugs for the treatment of respiratory system diseases and disorders; medicated lip balm; decoctions for pharmaceutical purposes for the treatment of respiratory system diseases and disorders; medicinal formulations for skin wounds, namely, pharmaceutical preparations for skin wounds; medicinal formulations for treating bone fractures, namely, pharmaceutical preparations for the treatment of bone fractures; paracetamol; anti-inflammatories; antidiarrheal medicines; pharmaceutical preparations for treating asthma; anti-allergy medications; antiviral preparations; pharmaceuticals for treating viral diseases; pharmaceutical preparations for treating allergies; bulk medicine used for treating cardiovascular and cerebrovascular diseases; vitamin supplement tablets; cough suppressant and phlegm relievers, namely, cough treatment preparations; injectable medications for allergic reactions; mosquito repellent patch for babies; medicated baby powder; fever reducer, namely, ibuprofen; antiemetic drugs, namely, nausea treatment preparations; cough suppressants, namely, cough expectorants; mosquito repellents for use on the skin; preparations for the treatment of heatstroke; anti-inflammatory spray; traditional Chinese medicinal herb preparations; cough drops; pain relief medications; chemotherapeutic drugs, namely, pharmaceutical preparations for use in chemotherapy; antibiotic for humans; medicated ointment for the treatment of dermatological conditions; ointment for treatment of skin diseases; medicated baby oil; ophthalmic pharmaceutical preparations; migraine treatment preparations; balsamic preparations for medical purposes; cough syrup for medical use; dermatological pharmaceuticals; anti-inflammatory preparations; expectorants; pharmaceutical preparations in the form of tablets for treating cardiovascular and cerebrovascular diseases; disinfectants; fever and pain relievers, namely, ibuprofen; anticoagulants; anti-inflammatory ointments; oral ibuprofen for pain relief; injectable pharmaceutical preparations for treating cardiovascular and cerebrovascular diseases; injectable dermal fillers; powdered milk for babies; lutein dietary supplements; dietetic foods adapted for medical use; medicated candies; lecithin dietary supplements; mineral dietary supplements; dietetic beverages adapted for medical use; dietetic foods adapted for medical purposes; baby cookies, namely, baby food; zinc dietary supplement; infant formula; lacteal flour for babies; dietetic beverages adapted for medical purposes; nutritional supplements; candy for pharmaceutical purpose for the treatment of respiratory system diseases and disorders; food for babies; milk sugar for pharmaceutical purposes; dietetic candies adapted for medical purposes; vitamin beverages adapted for medical purposes; casein dietary supplements; liquid formula for infants; linseed oil dietary supplements; protein dietary supplements; disposable baby diapers; baby swim diapers; diaper changing mats, disposable, for babies; disposable swim diapers for toddlers and infants; swim diapers, disposable, for babies; bandages for dressings; medical dressing; adhesive plasters for medical purposes; swim diapers, reusable, for babies |
Indication of Colors claimed | The color(s) red, black, yellow, and orange is/are claimed as a feature of the mark. |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Thursday, July 25, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | YABAO PHARMACEUTICAL GROUP CO., LTD. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | CN |
Party Name | YABAO PHARMACEUTICAL GROUP CO., LTD. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | CN |
Event Date | Event Description |
Thursday, July 25, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
Tuesday, August 20, 2024 | NON-FINAL ACTION WRITTEN |
Tuesday, August 20, 2024 | ASSIGNED TO EXAMINER |
Monday, August 26, 2024 | REFUSAL PROCESSED BY MPU |
Wednesday, July 31, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, July 31, 2024 | APPLICATION FILING RECEIPT MAILED |
Wednesday, August 21, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Monday, August 26, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Sunday, September 15, 2024 | REFUSAL PROCESSED BY IB |
Monday, January 20, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, January 20, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, January 20, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Friday, February 21, 2025 | EXAMINERS AMENDMENT -WRITTEN |
Friday, February 21, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Friday, February 21, 2025 | EXAMINERS AMENDMENT E-MAILED |
Friday, March 7, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Friday, February 21, 2025 | EXAMINER'S AMENDMENT ENTERED |
Friday, February 21, 2025 | ASSIGNED TO LIE |
Wednesday, March 26, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, April 1, 2025 | PUBLISHED FOR OPPOSITION |
Tuesday, April 1, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Friday, March 7, 2025 | LAW OFFICE PUBLICATION REVIEW COMPLETED |